5-Factor Prognostic Model For Survival Of Patients With Metastatic Urothelial Carcinoma Receiving Three Different Post-Platinum Pd-L1 Inhibitors.
Guru Sonpavde,Juliane Manitz,Chen Gao,Daniel Hennessy,Doris Makari,Guenter Niegisch,Jonathan E. Rosenberg,Dean F. Bajorin,Petros Grivas,Andrea B. Apolo,Robert Dreicer,Noah M. Hahn,Matt D. Galsky,Andrea Necchi,Sandy Srinivas,Thomas Powles,Ashok Kumar Gupta,Shaad Essa Abdullah,Gregory Russell Pond JOURNAL OF CLINICAL ONCOLOGY（2019）
AI 理解论文
溯源树
样例
